secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0000950170-23-053654
Event type: debt
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix repays $1.06M of convertible bond with equity, principal now $14.84M
------------------------------------------------------------------------------

- Repaid $1.06 million of convertible bond via 150,000 ordinary shares and 1,092,694 ADSs.
- Remaining convertible bond principal reduced to $14.84 million.
- Total shares outstanding after admission: 97,430,156 ordinary shares.
- New ordinary shares expected to be admitted to AIM on October 19, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023053654/0000950170-23-053654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023053654/rnlx-20231017.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-053654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer